Evaluation of the Clinical Efficacy and Safety of a Spot-on Combination of Imidacloprid 10 % / Moxidectin 2.5 % (Advocate®, Advantage® Multi) in Comparison to an Untreated Control Group in the Treatment of Capillaria boehmi in Naturally Infected Dogs
Sign Up to like & getrecommendations! Published in 2017 at "Parasitology Research"
DOI: 10.1007/s00436-017-5492-0
Abstract: Capillaria boehmi affects the upper respiratory tract of domestic and wild canids. The aim of the present study was to investigate the efficacy of imidacloprid 10 % / moxidectin 2.5 % spot-on (Advocate®, Advantage® Multi,… read more here.
Keywords: advocate advantage; advantage multi; treatment; efficacy ... See more keywords
Efficacy of imidacloprid 10%/moxidectin 2.5% spot on (Advocate®, Advantage Multi®) and doxycycline for the treatment of natural Dirofilaria immitis infections in dogs.
Sign Up to like & getrecommendations! Published in 2019 at "Veterinary parasitology"
DOI: 10.1016/j.vetpar.2019.07.011
Abstract: Heartworm infection (also known as dirofilariosis due to Dirofilaria immitis) in dogs causes chronic pulmonary disease that, if left untreated, can lead to right-side congestive heart failure. Currently, the only registered drug for adulticide therapy… read more here.
Keywords: imidacloprid moxidectin; treatment; doxycycline; dirofilaria immitis ... See more keywords